# Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate

> **NCT00141908** · PHASE2 · COMPLETED · sponsor: **American University of Beirut Medical Center** · enrollment: 290 (estimated)

## Conditions studied

- Preterm Delivery

## Interventions

- **DRUG:** 17-alpha Hydroxyprogesterone Caproate
- **DRUG:** Castor oil

## Key facts

- **NCT ID:** NCT00141908
- **Lead sponsor:** American University of Beirut Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 290 (ESTIMATED)
- **Last updated:** 2013-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00141908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00141908, "Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00141908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*